← FDA DRUG APPROVALS

FDA NDA · NDA019489

VENTOLIN ROTACAPS

Sponsor: GLAXOSMITHKLINE

APPLICATION
NDA019489
TYPE
NDA
ORIGINAL APPROVAL
1988-05-04
LATEST ACTION
1999-06-30
ROUTE
INHALATION
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

VENTOLIN ROTACAPSDiscontinued
ALBUTEROL SULFATE EQ 0.2MG BASE · CAPSULE · INHALATION

Approval history

1999-06-30Manufacturing (CMC) · Supplement 19 · standardAP
1998-07-30Labeling · Supplement 18 · standardAP
1996-12-26Manufacturing (CMC) · Supplement 16 · standardAP
1995-01-26Manufacturing (CMC) · Supplement 13 · standardAP
1994-06-14Labeling · Supplement 12 · standardAP
1994-01-27Labeling · Supplement 11 · standardAP
1993-08-18Manufacturing (CMC) · Supplement 10 · standardAP
1993-07-20Efficacy · Supplement 8 · standardAP
1992-12-15Manufacturing (CMC) · Supplement 3 · standardAP
1992-10-28Labeling · Supplement 7 · standardAP
1992-05-21Labeling · Supplement 6 · standardAP
1992-04-06Manufacturing (CMC) · Supplement 5 · standardAP
1990-09-24Efficacy · Supplement 1 · standardAP
1990-09-24Labeling · Supplement 2 · standardAP
1988-05-04Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →